Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression

Basal-type triple-negative breast cancers (TNBC) are aggressive and difficult to treat relative to luminal type breast cancers. TNBC often express abundant Met receptors and are enriched for transcriptional targets regulated by hypoxia inducible factor 1-alpha (HIF-1α), which independently predicts...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Regan Anderson, Tarah M., Peacock, Danielle L., Daniel, Andrea R., Hubbard, Gregory K., Lofgren, Kristopher A., Girard, Brian J., Schörg, Alexandra, Hoogewijs, David, Wenger, Roland H., Seagroves, Tiffany N., Lange, Carol A.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3820501/
https://ncbi.nlm.nih.gov/pubmed/23928995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0523
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items